33% of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to Mr. Melnikoff’s continued employment by the Company on the applicable vesting date.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health and promoting general wellness through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. The company’s is focused on the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
Source: electroCore, Inc.
2024 GlobeNewswire, Inc., source